MedTrace Logo

Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder

NCT06001398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-01-15

Study results available
· View outcomes & findings →

Summary

This is a pilot study of randomized clinical trial of Parent Acceptance and Commitment Therapy (PACT) vs. an attention-control condition (placebo) for improving the mental health of parents of children with pediatric feeding disorder.

The goal of this clinical trial is to compare two programs in parents of children with pediatric feeding disorders.

The main question\[s\] it aims to answer are:

* PACT will result in clinically meaningful reductions in Mental Health(MH) problems among parents of children with Pediatric Feed Disorder (PFD)
* Identify factors that impact the feasibility of PACT delivery

* Participants will asked to participate in one of two programs focused on parents of children with pediatric feeding disorders.
* The participants will also be asked to complete a battery of questionnaires at four timepoints during the study.
* The parents will be asked to video record a meal time twice during study.

If there is a comparison group: Researchers will compare the PACT group with a control group to see if PACT will result in clinically meaningful change in parent stress and anxiety, and parent use of positive mealtime behaviors.

Conditions

  • Pediatric Feeding Disorder, Chronic
  • Pediatric Feeding Dysfunction, Acute

Interventions

BEHAVIORAL

Parent Acceptance and Commitment Therapy (PACT)

PACT is a 2-session intervention based on the Focused Acceptance and Commitment Therapy treatment literature

BEHAVIORAL

Control

The content of the control intervention covers a range of nutrition and healthy lifestyle topics including USDA's MyPlate

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Dana Bakula, PhD · Children's Mercy Hosptial

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-27
Primary Completion
2024-10-01
Completion
2025-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06001398 on ClinicalTrials.gov